Immunohistochemical evaluation of the safety of transurethral electrovaporization of the prostate and its clinical results

Citation
A. Tizzani et al., Immunohistochemical evaluation of the safety of transurethral electrovaporization of the prostate and its clinical results, PROSTATE C, 2(1), 1999, pp. 16-20
Citations number
28
Categorie Soggetti
Urology & Nephrology
Journal title
PROSTATE CANCER AND PROSTATIC DISEASES
ISSN journal
13657852 → ACNP
Volume
2
Issue
1
Year of publication
1999
Pages
16 - 20
Database
ISI
SICI code
1365-7852(199901)2:1<16:IEOTSO>2.0.ZU;2-Z
Abstract
Short term follow up studies on transurethral electrovaporization (TUEVP) h ave shown a relative low morbidity over TURF. The use of high power current has been claimed as a source of possible damage on the neuronal structures surrounding the prostate. The aims of our study were to assess longer follow up results as well as th e safety of this technique. Over an 18 month mean follow up period symptom relief remained relatively s table. Postoperative dysuria was detected in a higher percentage of patient s and was seen for a longer period in comparison with previous reports. Immunohistochemical staining performed using S-100 and NF monoclonal antibo dies showed anatomical integrity of the prostatic neuronal fibres surroundi ng the vaporization edge. In conclusion, although the effectiveness and safety of TUEVP are confirmed by the present study, the occurrence of a significant rate of long-lasting postoperative irritative symptoms must be taken into account.